Estrella Immunopharma Inc (ESLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 169 | 2,741 | 2,756 | 2,885 | 424 |
| Operating Income | -169 | -2,741 | -2,756 | -2,885 | -424 |
| Other Income | 114 | 0 | 0 | 0 | 64 |
| Pre-tax Income | -55 | -2,741 | -2,756 | -2,885 | -360 |
| Income Tax | 21 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -76 | -2,741 | -2,756 | -2,885 | -360 |
| Net Income | $-76 | $-2,741 | $-2,756 | $-2,885 | $-360 |
| EPS Basic Total Ops | -0.13 | -8.13 | -16.33 | -34.33 | -0.06 |
| EPS Basic Continuous Ops | -0.05 | -8.13 | -16.33 | -34.33 | -0.25 |
| EPS Diluted Total Ops | -0.13 | -8.13 | -16.33 | -34.33 | -0.06 |
| EPS Diluted Continuous Ops | -0.05 | -8.13 | -16.33 | -34.33 | -0.25 |
| EBITDA(a) | $-169 | $-2,727 | $-2,756 | $-2,885 | $-424 |